|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 471 articles |
 Page 1 of 7 
|
Vectura seeks AIM listing and placing.(Brief Article)
June 28, 2004
Survey reveals challenges facing autoimmune disease research.(Brief Ar...
June 28, 2004
UK Seroxat law suit "weeks away".(Brief Article)
June 28, 2004
Tercica pays Genentech $1.3 million under IGF-1 combined with IGFBP-3 ...
June 28, 2004
Zambon Spain sees 2004 profits hit by new pharmaceutical reference pri...
June 28, 2004
Merck & Co and Vertex sign VX-680 accord.(Brief Article)
June 28, 2004
Russian Minister's pledge on drug costs.(Brief Article)
June 28, 2004
Euro Rx R&D chiefs pledge cooperation.(Brief Article)
June 28, 2004
Solvay awarded $68 million in Barr dispute.(Brief Article)
June 28, 2004
Sinclair files for US approval of Decapinol.(Brief Article)
June 28, 2004
S Africa: 2003 drug production data.(Brief Article)
June 28, 2004
B-MS and Otsuka's Abilify launched in EU.(Brief Article)
June 28, 2004
Spain's Farmasierra sees profits rising 20%.(Brief Article)
June 28, 2004
Ratiopharm on acquisition trail.(Brief Article)
June 28, 2004
bioMerieux goes for July listing; major changes and new structure.
June 28, 2004
Bayer and UN partner in youth environmental projects.(United Nations E...
June 28, 2004
Chinese pharma local market share growing.(Brief Article)
June 28, 2004
Zentiva's offer price set at 485 koruna a share.(Brief Article)
June 28, 2004
Praecis resumes trials for cancer drug.(Brief Article)
June 28, 2004
Xenova's clinical trial manufacturing facility OKed by MHRA.(Medicines...
June 28, 2004
Watson's oxybutynin patch gets EU OK.(Brief Article)
June 28, 2004
GSK granted new license for Imigran to treat migraines.(Brief Article)
June 28, 2004
S Africa High Court reserves judgement on med regs; ruling "by early A...
June 28, 2004
S-P's Remicade cleared in EU for early RA.(Brief Article)
June 28, 2004
Tercica and ABAXIS join USA's Russell indexes.(Brief Article)
June 28, 2004
Elan's holding of Bioject stock clarified.(Brief Article)
June 28, 2004
Roche and Kosan stop KOS-862 cancer trial.(Brief Article)
June 28, 2004
Sanofi sets up team to integrate Aventis.(Brief Article)
June 28, 2004
Schering-Plough shares rise on Toyama deal for garenoxacin license.
June 28, 2004
GSK in COMESA.(Brief Article)
June 28, 2004
US FDA could award glucosamine and chondroitin health claims by Sept?(...
June 28, 2004
UK Parliament to probe pharma "influence".(House of Commons Health Com...
June 28, 2004
Two Cipla ARVs off WHO pre-qualification list due to bioequivalence, o...
June 28, 2004
Soy may help reduce risk of developing cancer of the womb.
June 28, 2004
Wilex' Rencarex enters Phase III.(Brief Article)
June 28, 2004
Teva/Aventis launch pre-filled Copaxine syringe in Europe.(Brief Artic...
June 28, 2004
Indian govt pledge on life-saving drug prices.(Brief Article)
June 28, 2004
NovaDel's nitroglycerin spray filed in USA.(Brief Article)
June 28, 2004
New use in EU for Roche's Herceptin.(Brief Article)
June 28, 2004
Western drugmakers make inroads in Japan.(Brief Article)
June 28, 2004
CellExSys to merge with Chromos.(Brief Article)
June 28, 2004
Uganda launches free HIV/AIDS drug program.(Brief Article)
June 28, 2004
Vietnamese pharma upbeat on supply targets.(Brief Article)
June 28, 2004
New Zealand Pharmac drug price warning.(Brief Article)
June 28, 2004
Tanzania plans free ARV program by October.(Brief Article)
June 28, 2004
Roche expands biotech production capacity.(Brief Article)
June 28, 2004
Genepharm to register 20 drugs over next year.(Genepharm Australasia)(...
June 28, 2004
Novartis' Diovan as effective as Norvasc in hypertensive patients with...
June 28, 2004
Titan halts Pivanex NSCLC trial.(Non-small Cell Lung Cancer)(Titan )(B...
June 28, 2004
Vicuron to reduce costs due to anidulaflungin delay.(Brief Article)
June 28, 2004
Mitsui to take 20% stake in Quintiles' Japanese subsidiary.(Brief Arti...
June 28, 2004
Stock Commentary - Europe.(Brief Article)
June 28, 2004
Barrier's liarozole designated Orphan Drug Status by the FDA.(Brief Ar...
June 28, 2004
Zeltia receives approval from FDA to start Phase II trials of Aplidin....
June 28, 2004
Amrad's Emfilermin ineffective in helping infertile women fall pregnan...
June 28, 2004
Basilea promotes Rienk Pypstra to chief development officer.(Brief Art...
June 28, 2004
Zafiris Zafirelis named CEO of Biopure.(Brief Article)
June 28, 2004
Ranbaxy debuts chewable cephalosporin tab.(Brief Article)
June 28, 2004
PTC Therapeutics closes $50M private placement.(Brief Article)
June 28, 2004
FDA clears additional claims for Bayer's BNP test.(Brief Article)
June 28, 2004
Illegal Chinese medicines seized in Australia.(Brief Article)
June 28, 2004
Sigma-Aldrich expands in fine chemicals with Tetrionics acquisition.(B...
June 28, 2004
Ph III data for GW's Sativex in MS.
June 28, 2004
New data show Merck Sharp and Dohme's Cozaar to be cost-effective.(Bri...
June 28, 2004
ImClone names Michael Howerton CFO.(Brief Article)
June 28, 2004
Isis earns $1M milestone on Macugen filing.(Brief Article)
June 28, 2004
Lehman Bros forecast peak sales of Raptiva at $250M.(Brief Article)
June 28, 2004
Axis-Shield expects 9% organic growth for 1st-half.(Brief Article)
June 28, 2004
NexMed raises $8.27M from private placement.(Brief Article)
June 28, 2004
Approval letter for Pfizer's Cardura XL.(Brief Article)
June 28, 2004
Stock Commentary - New York.
June 28, 2004
Inflazyme halts development of IPL512,602.(Brief Article)
June 28, 2004
John Greisch promoted to CFO of Baxter International.(Brief Article)
June 28, 2004
Michael Marquard joins Mylan.(Brief Article)
June 28, 2004
Hannes Smarason steps down at deCODE.(Brief Article)
June 28, 2004
|
1